BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22008091)

  • 1. The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications?
    Takeuchi M; Yasunaga H; Horiguchi H; Matsuda S
    Epidemiol Infect; 2012 Aug; 140(8):1497-502. PubMed ID: 22008091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis hospitalizations among infants in the United States, 1993 to 2004.
    Cortese MM; Baughman AL; Zhang R; Srivastava PU; Wallace GS
    Pediatrics; 2008 Mar; 121(3):484-92. PubMed ID: 18310196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.
    Kolos V; Menzies R; McIntyre P
    Vaccine; 2007 Jan; 25(4):588-90. PubMed ID: 16971026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis after end of a mass vaccination project--end of the "vaccination honey-moon".
    Trollfors B; Dotevall L; Sundh V; Welinder-Olsson C
    Vaccine; 2011 Mar; 29(13):2444-50. PubMed ID: 21292010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of additional pertussis vaccine doses on disease incidence in children and infants.
    Stein-Zamir C; Shoob H; Abramson N; Zentner G
    Vaccine; 2010 Dec; 29(2):207-11. PubMed ID: 21055497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis in infants: preventing deaths and hospitalisations in the very young.
    Wood N; Quinn HE; McIntyre P; Elliott E
    J Paediatr Child Health; 2008 Apr; 44(4):161-5. PubMed ID: 18377367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pertussis in the Netherlands].
    de Greeff SC; de Melker HE; Mooi FR
    Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].
    de Greeff SC; Schellekens JF; Mooi FR; de Melker HE
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.
    Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G
    Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in australia.
    Foxwell AR; McIntyre P; Quinn H; Roper K; Clements MS
    Pediatr Infect Dis J; 2011 Feb; 30(2):161-3. PubMed ID: 20811313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization.
    Skowronski DM; Janjua NZ; Tsafack EP; Ouakki M; Hoang L; De Serres G
    Clin Infect Dis; 2012 Feb; 54(3):318-27. PubMed ID: 22156850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT).
    Halperin SA; Wang EE; Law B; Mills E; Morris R; Déry P; Lebel M; MacDonald N; Jadavji T; Vaudry W; Scheifele D; Delage G; Duclos P
    Clin Infect Dis; 1999 Jun; 28(6):1238-43. PubMed ID: 10451159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of birth certificates and surveillance data to characterize reported pertussis among Texas infants and young children, 1995 to 2000.
    Pelosi JW; Schulte JM
    South Med J; 2003 Dec; 96(12):1231-7. PubMed ID: 14696875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.